1
FORM 8-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report October 22, 1999
DURAMED PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-15242 11-2590026
- --------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
7155 East Kemper Road, Cincinnati, Ohio 45249 (513) 731-9900
- --------------------------------------------------------------------------------
(Address of principal executive offices)
2
INFORMATION TO BE INCLUDED IN THE REPORT
Items 1, 2, 3, 4, 6 and 8 are not applicable and are omitted from this Report.
Item 5. Other Events
------------
The Company's press release dated October 22, 1999 is attached hereto
as Exhibit 99 and is incorporated herein by reference.
Item 7. Financial Statements Information and Exhibits
---------------------------------------------
(a) Financial Statements of Businesses Acquired.
Not Applicable
(b) Pro Forma Financial Information.
Not Applicable
(c) Exhibits.
The following exhibits are filed with this Report on
Form 8-K:
Regulation S-K
Exhibit No. Exhibit
----------- -------
99 Press release dated
October 22, 1999
-2-
3
SIGNATURES
----------
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Date: October 27, 1999 DURAMED PHARMACEUTICALS, INC.
By: /s/ Timothy J. Holt
-------------------------------------
Timothy J. Holt
Senior Vice President-Finance
and Administration